PrairieView Partners’s Sabra Healthcare REIT SBRA Stock Holding History

PrairieView Partners’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-27	Closed	–	–	479
2022 Q1	$0	Buy	+27	New	+$369	﹤0.01%	479

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PrairieView Partners's SBRA Position: Q2 2022 in Review

PrairieView Partners sold out of Sabra Healthcare REIT (SBRA) in Q2 2022, closing a stake of 27 shares.

PrairieView Partners first reported a position in SBRA in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 332 funds tracked by Wall St. Rank hold SBRA as of Q2 2022.

PrairieView Partners reported no remaining Sabra Healthcare REIT position as of Q2 2022 after selling out during the quarter.
PrairieView Partners sold 27 Sabra Healthcare REIT shares in Q2 2022.
PrairieView Partners first reported a position in Sabra Healthcare REIT in Q1 2022 and held it in 1 quarter.
PrairieView Partners's Sabra Healthcare REIT position peaked at $0 in Q1 2022.
332 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2022.

Based on PrairieView Partners's 13F filing for Q2 2022, filed 22 Jul 2022.